微信:去年用戶通過微信支付繳納社保逾7.5億筆
騰訊(00700.HK)旗下微信發布《2021微信支付智慧社保數據報告》,數據顯示,去年用戶通過微信支付繳納社保超過7.5億筆,按年增長逾30%,用戶人均繳費523元人民幣,另外有超過1.1億用戶異地繳納社保。
微信表示,多地社保數字化程度進一步提高,去年內蒙古、上海、安徽、寧夏、深圳相繼開通小程序繳納社保的通道,全國支持小程序登陸社保繳費的省市和地區增至25個,全國已有31個省市和地區支持通過微信支付繳納社保。所有使用微信支付繳納社保的用戶中,通過微信公眾號或小程序繳費的佔比達90%以上。
微信表示,未來微信支付將持續完善產品功能,探索更多創新的應用和場景,讓更多用戶享受到「指尖繳費」的便利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.